Name: Monoclonal Antibody Therapy of Human Cancer (en Inglés)
Price: 137910.00 CLP
Availability: InStock
Author: Foon, Kenneth A. ; Morgan, Alton C.
ISBN: 9781461296423

portada Monoclonal Antibody Therapy of Human Cancer (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Foon, Kenneth A. ; Morgan, Alton C.

Idioma

Inglés

N° páginas

162

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 1.0 cm

Peso

0.26 kg.

ISBN13

9781461296423

Categorías

Oncología
Jardinería

Monoclonal Antibody Therapy of Human Cancer (en Inglés)

Foon, Kenneth A. ; Morgan, Alton C. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 137.910

$ 250.740

Ahorras: $ 112.830

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 25 de Julio y el Martes 06 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Monoclonal Antibody Therapy of Human Cancer (en Inglés)"

KENNETH A. FOON and ALTON C. MORGAN, JR. Passive immunotherapy using heteroantisera for the treatment of cancer in animals and humans has been studied for over 50 years. Attempts have been made to treat animal tumors with sera from immunized syngeneic, allogeneic, or xenogeneic animals. A number of studies of passive immunotherapy using heterologous antisera in humans have also been performed. These studies have generally been attempted in patients with large tumor burdens, and as would be expected, results have been transient at best. A wide variety of solid tumors as well as leukemias and lym- phomas have been treated with antisera raised in sheep, horses, rabbits, and goats. Problems such as anaphylaxis, serum sick- ness, and severe cytopenias have been encountered with these antisera. There are a number of potential mechanisms by which unconju- gated antibodies might be cytotoxic to tumor cells. Antibodies bound to the cell surface membrane of tumor cells may lead to cell lysis by complement-dependent or antibody-dependent cellu- lar cytotoxicity. Circulating tumor cells bound by antibody may be more susceptible to phagocytosis by the reticuloendothelial system. Antibody bound to the cell surface membrane of tumor cells may enhance immunogenicity of the tumor cell leading to activation of the host's immune system.